Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for RDY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
June 30, 2026 6.078B
March 31, 2026 6.108B
December 31, 2025 6.263B
September 30, 2025 6.104B
June 30, 2025 6.058B
March 31, 2025 5.768B
December 31, 2024 5.619B
September 30, 2024 5.560B
June 30, 2024 4.980B
March 31, 2024 4.646B
December 31, 2023 4.481B
September 30, 2023 4.179B
June 30, 2023 4.084B
March 31, 2023 3.916B
December 31, 2022 3.739B
September 30, 2022 3.577B
June 30, 2022 3.748B
March 31, 2022 3.864B
December 31, 2021 3.800B
September 30, 2021 3.752B
June 30, 2021 3.743B
March 31, 2021 3.631B
December 31, 2020 3.454B
September 30, 2020 3.434B
June 30, 2020 3.328B
Date Value
March 31, 2020 3.070B
December 31, 2019 3.053B
September 30, 2019 3.300B
June 30, 2019 3.290B
March 31, 2019 3.254B
December 31, 2018 3.247B
September 30, 2018 3.231B
June 30, 2018 3.370B
March 31, 2018 3.459B
December 31, 2017 3.541B
September 30, 2017 3.399B
June 30, 2017 2.939B
March 31, 2017 3.385B
December 31, 2016 3.346B
September 30, 2016 3.311B
June 30, 2016 2.898B
March 31, 2016 3.136B
December 31, 2015
September 30, 2015 3.084B
June 30, 2015
March 31, 2015 3.112B
December 31, 2014
September 30, 2014 2.855B
June 30, 2014
March 31, 2014 2.850B

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Takeda Pharmaceutical Co., Ltd. 96.37B
Teva Pharmaceutical Industries Ltd. 39.86B
Novo Nordisk A/S 91.00B
Perrigo Co. Plc 7.610B
Innoviva, Inc. 1.703B

Total Assets (Quarterly) Related Metrics